Powered by

Flagship Pioneering Unveils Inzen Therapeutics; Company developing new class of transformative medicines based on Thanokine Biology

Jan 13, 2021 - PR Newswire
Board and Executive Moves-Product Launch

PR Newswire

 Flagship Pioneering, a life science platforms company, today announced the unveiling of Inzen Therapeutics. Flagship created Inzen in 2017 to discover and develop a novel class of medicines based on a previously unrecognized area of biology that exerts broad and fundamental influence on cell state, discovered and named Thanokine™ Biology by Flagship's scientists.  Flagship also announced the appointment of industry veteran Volker Herrmann, M.D., M.B.A. as the company's new...